Supernus Pharmaceuticals
SUPN
#4425
Rank
C$2.58 B
Marketcap
$46.23
Share price
-0.40%
Change (1 day)
0.13%
Change (1 year)

P/S ratio for Supernus Pharmaceuticals (SUPN)

P/S ratio as of March 2025 (TTM): 2.72

According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.74. At the end of 2024 the company had a P/S ratio of 3.10.

P/S ratio history for Supernus Pharmaceuticals from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.1019.2%
20232.60-9.95%
20222.898.04%
20212.674.64%
20202.56-19.44%
20193.17-25.35%
20184.25-37.11%
20176.7616.17%
20165.8229.35%
20154.5016.32%
20143.87-84.58%
201325.1-83.1%
2012148

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
4.76 74.74%๐Ÿ‡บ๐Ÿ‡ธ USA
16.4 500.65%๐Ÿ‡บ๐Ÿ‡ธ USA
2.51-7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
5.44 99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
4.45 63.37%๐Ÿ‡บ๐Ÿ‡ธ USA